ArticleEuropean urology2018

Re: Effect of Longer-interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases.

Chris ParkerPubMed ↗Publisher ↗

No numbers read from the abstract.